BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26545243)

  • 1. Evaluation of High-Throughput Genomic Assays for the Fc Gamma Receptor Locus.
    Hargreaves CE; Iriyama C; Rose-Zerilli MJ; Nagelkerke SQ; Hussain K; Ganderton R; Lee C; Machado LR; Hollox EJ; Parker H; Latham KV; Kuijpers TW; Potter KN; Coupland SE; Davies A; Stackpole M; Oates M; Pettitt AR; Glennie MJ; Cragg MS; Strefford JC
    PLoS One; 2015; 10(11):e0142379. PubMed ID: 26545243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Human FcγR Gene Polymorphisms on IgG-Triggered Cytokine Release: Critical Importance of Cell Assay Format.
    Hussain K; Hargreaves CE; Rowley TF; Sopp JM; Latham KV; Bhatta P; Sherington J; Cutler RM; Humphreys DP; Glennie MJ; Strefford JC; Cragg MS
    Front Immunol; 2019; 10():390. PubMed ID: 30899264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copy number variation at the FCGR locus includes FCGR3A, FCGR2C and FCGR3B but not FCGR2A and FCGR2B.
    Breunis WB; van Mirre E; Geissler J; Laddach N; Wolbink G; van der Schoot E; de Haas M; de Boer M; Roos D; Kuijpers TW
    Hum Mutat; 2009 May; 30(5):E640-50. PubMed ID: 19309690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotyping Single Nucleotide Polymorphisms and Copy Number Variability of the FCGRs Expressed on NK Cells.
    Erbe AK; Wang W; Gallenberger M; Hank JA; Sondel PM
    Methods Mol Biol; 2016; 1441():43-56. PubMed ID: 27177655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Fcγ receptor IIB polymorphism with cryptococcal meningitis in HIV-uninfected Chinese patients.
    Hu XP; Wu JQ; Zhu LP; Wang X; Xu B; Wang RY; Ou XT; Weng XH
    PLoS One; 2012; 7(8):e42439. PubMed ID: 22879986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of allele copy number of polymorphisms in FCGR3A and FCGR3B genes on susceptibility to ulcerative colitis.
    Asano K; Matsumoto T; Umeno J; Hirano A; Esaki M; Hosono N; Matsui T; Kiyohara Y; Nakamura Y; Kubo M; Kitazono T
    Inflamm Bowel Dis; 2013 Sep; 19(10):2061-8. PubMed ID: 23917248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variations in low-to-medium-affinity Fcγ receptors and autoimmune neutropenia in early childhood in a Danish cohort.
    Kløve-Mogensen K; Steffensen R; Masmas TN; Glenthøj A; Jensen CF; Haunstrup TM; Ratcliffe P; Höglund P; Hasle H; Nielsen KR
    Int J Immunogenet; 2023 Apr; 50(2):65-74. PubMed ID: 36754570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Variation in Low-To-Medium-Affinity Fcγ Receptors: Functional Consequences, Disease Associations, and Opportunities for Personalized Medicine.
    Nagelkerke SQ; Schmidt DE; de Haas M; Kuijpers TW
    Front Immunol; 2019; 10():2237. PubMed ID: 31632391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fc-Gamma Receptor Polymorphisms Predispose Patients to Infectious Complications After Liver Transplantation.
    Shimizu S; Tanaka Y; Tazawa H; Verma S; Onoe T; Ishiyama K; Ohira M; Ide K; Ohdan H
    Am J Transplant; 2016 Feb; 16(2):625-33. PubMed ID: 26517570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-nucleotide polymorphisms and copy number variations of the
    Moriya H; Saito K; Helsby N; Hayashi N; Sugino S; Yamakage M; Sawaguchi T; Takasaki M; Takahashi M; Kurosawa N
    Biomed Rep; 2014 Mar; 2(2):265-269. PubMed ID: 24649108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Fc-γ Receptor Polymorphism on Rituximab-Mediated B Cell Depletion in ABO-Incompatible Adult Living Donor Liver Transplantation.
    Sakai H; Tanaka Y; Tazawa H; Shimizu S; Verma S; Ohira M; Tahara H; Ide K; Ishiyama K; Kobayashi T; Onoe T; Ohdan H
    Transplant Direct; 2017 Jun; 3(6):e164. PubMed ID: 28620648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility.
    Kyogoku C; Dijstelbloem HM; Tsuchiya N; Hatta Y; Kato H; Yamaguchi A; Fukazawa T; Jansen MD; Hashimoto H; van de Winkel JG; Kallenberg CG; Tokunaga K
    Arthritis Rheum; 2002 May; 46(5):1242-54. PubMed ID: 12115230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Fcγ receptor IIIa and IIa polymorphisms: lack of correlation with outcome in trastuzumab-treated breast cancer patients.
    Hurvitz SA; Betting DJ; Stern HM; Quinaux E; Stinson J; Seshagiri S; Zhao Y; Buyse M; Mackey J; Driga A; Damaraju S; Sliwkowski MX; Robert NJ; Valero V; Crown J; Falkson C; Brufsky A; Pienkowski T; Eiermann W; Martin M; Bee V; Marathe O; Slamon DJ; Timmerman JM
    Clin Cancer Res; 2012 Jun; 18(12):3478-86. PubMed ID: 22504044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab.
    Zhang W; Gordon M; Schultheis AM; Yang DY; Nagashima F; Azuma M; Chang HM; Borucka E; Lurje G; Sherrod AE; Iqbal S; Groshen S; Lenz HJ
    J Clin Oncol; 2007 Aug; 25(24):3712-8. PubMed ID: 17704420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone.
    Persky DO; Dornan D; Goldman BH; Braziel RM; Fisher RI; Leblanc M; Maloney DG; Press OW; Miller TP; Rimsza LM
    Haematologica; 2012 Jun; 97(6):937-42. PubMed ID: 22271896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integrated approach for measuring copy number variation at the FCGR3 (CD16) locus.
    Hollox EJ; Detering JC; Dehnugara T
    Hum Mutat; 2009 Mar; 30(3):477-84. PubMed ID: 19143032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fc-gamma receptor polymorphisms differentially influence susceptibility to systemic lupus erythematosus and lupus nephritis.
    Tsang-A-Sjoe MW; Nagelkerke SQ; Bultink IE; Geissler J; Tanck MW; Tacke CE; Ellis JA; Zenz W; Bijl M; Berden JH; de Leeuw K; Derksen RH; Kuijpers TW; Voskuyl AE
    Rheumatology (Oxford); 2016 May; 55(5):939-48. PubMed ID: 26748351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fc gamma receptor IIIa polymorphisms in advanced colorectal cancer patients correlated with response to anti-EGFR antibodies and clinical outcome.
    Calemma R; Ottaiano A; Trotta AM; Nasti G; Romano C; Napolitano M; Galati D; Borrelli P; Zanotta S; Cassata A; Castello G; Iaffaioli VR; Scala S
    J Transl Med; 2012 Nov; 10():232. PubMed ID: 23171437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extensive Ethnic Variation and Linkage Disequilibrium at the
    Nagelkerke SQ; Tacke CE; Breunis WB; Tanck MWT; Geissler J; Png E; Hoang LT; van der Heijden J; Naim ANM; Yeung RSM; Levin ML; Wright VJ; Burgner DP; Ponsonby AL; Ellis JA; Cimaz R; Shimizu C; Burns JC; Fijnvandraat K; van der Schoot CE; van den Berg TK; de Boer M; Davila S; Hibberd ML; Kuijpers TW;
    Front Immunol; 2019; 10():185. PubMed ID: 30949161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancer.
    Mellor JD; Brown MP; Irving HR; Zalcberg JR; Dobrovic A
    J Hematol Oncol; 2013 Jan; 6():1. PubMed ID: 23286345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.